DURECT Corp.
(NASDAQ : DRRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.71%30.2614.1%$178.05m
AMRNAmarin Corp. Plc -0.75%19.911.7%$159.55m
AXSMAxsome Therapeutics, Inc. -2.31%90.341.9%$129.63m
SAVACassava Sciences, Inc. -4.40%8.250.0%$91.12m
ARQLArQule, Inc. 0.15%20.000.6%$78.96m
BHCBausch Health Cos., Inc. 1.71%30.260.0%$74.96m
SAGESAGE Therapeutics, Inc. 3.12%76.408.6%$70.78m
GWPHGW Pharmaceuticals Plc -0.13%118.976.2%$70.43m
JAZZJazz Pharmaceuticals Plc -0.36%151.052.3%$67.88m
ICPTIntercept Pharmaceuticals, Inc. -3.76%106.1116.9%$63.50m
PRGOPerrigo Co. Plc -0.82%59.026.8%$58.61m
HZNPHorizon Therapeutics Plc 0.29%38.406.6%$57.70m
ENDPEndo International Plc -2.27%6.048.8%$42.46m
ICLRICON plc 0.38%175.784.2%$41.39m
CTLTCatalent, Inc. -1.03%60.842.4%$37.19m

Company Profile

DURECT Corp. is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.